We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Exiqon to Present New Data at AACR Conference
News

Exiqon to Present New Data at AACR Conference

Exiqon to Present New Data at AACR Conference
News

Exiqon to Present New Data at AACR Conference

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Exiqon to Present New Data at AACR Conference"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Exiqon A/S has announced that data from its diagnostic program on early detection of colorectal cancer in plasma has been selected for oral presentation at the 102nd Annual American Association for Cancer Research (AACR) Meeting to be held 2-6 April in Orlando, Florida.

The presentation is scheduled to be held on Monday, 4 April 2011, 3:00 PM - 5:00 PM (EST). The title of the presentation is “Discovery of a miRNA-based RT qPCR signature able to detect early stage colorectal cancer in blood plasma."

“The selection for presentation at the AACR is a great acknowledgement of the robust diagnostic PCR platform Exiqon has built, and the ability to use miRNA present in blood-derived serum or plasma as biomarkers. We have completed our discovery studies in 400 patients and controls, and we have access to 5,000 patients for our validation study which we expect to be completed by the end of the year,” said Lars Kongsbak, president and CEO.

Exiqon will announce data from the study on Monday, 4 April 2011 at the time of the presentation.

Advertisement